|
AU2002216863B8
(en)
*
|
2000-12-21 |
2008-03-20 |
Id Biomedical Corporation |
Streptococcus pyogenes antigens and corresponding DNA fragments
|
|
CN105142672B
(zh)
|
2012-10-23 |
2019-04-05 |
西纳福克斯股份有限公司 |
经修饰的抗体、抗体-缀合物及其制备方法
|
|
PL2991683T3
(pl)
*
|
2013-05-02 |
2020-03-31 |
Glykos Finland Oy |
Koniugaty glikoproteiny lub glikanu z toksycznym ładunkiem
|
|
US9987373B2
(en)
|
2013-10-14 |
2018-06-05 |
Synaffix B.V. |
Modified glycoprotein, protein-conjugate and process for the preparation thereof
|
|
WO2015057063A1
(en)
|
2013-10-14 |
2015-04-23 |
Synaffix B.V. |
Modified glycoprotein, protein-conjugate and process for the preparation thereof
|
|
WO2015057066A1
(en)
|
2013-10-14 |
2015-04-23 |
Synaffix B.V. |
Glycoengineered antibody, antibody-conjugate and methods for their preparation
|
|
US20160235861A1
(en)
|
2013-10-14 |
2016-08-18 |
SynAffix. B.V. |
Glycoengineered antibody, antibody-conjugate and methods for their preparation
|
|
GB201318490D0
(en)
*
|
2013-10-18 |
2013-12-04 |
Genovis Ab |
Method
|
|
US11168085B2
(en)
|
2014-01-24 |
2021-11-09 |
Synaffix B.V. |
Process for the cycloaddition of a hetero(aryl) 1,3-dipole compound with a (hetero)cycloalkyne
|
|
EP3160513B1
(en)
|
2014-06-30 |
2020-02-12 |
Glykos Finland Oy |
Saccharide derivative of a toxic payload and antibody conjugates thereof
|
|
GB201413240D0
(en)
*
|
2014-07-25 |
2014-09-10 |
Hansa Medical Ab |
Method
|
|
EP4148138A1
(en)
|
2014-08-04 |
2023-03-15 |
SynAffix B.V. |
Process for the modification of a glycoprotein using a beta-(1,4)-n-acetylgalactosaminyltransferase or a mutant thereof
|
|
GB201502306D0
(en)
*
|
2015-02-12 |
2015-04-01 |
Hansa Medical Ab |
Protein
|
|
GB201502305D0
(en)
*
|
2015-02-12 |
2015-04-01 |
Hansa Medical Ab |
Protein
|
|
WO2016170186A1
(en)
|
2015-04-23 |
2016-10-27 |
Synaffix B.V. |
PROCESS FOR THE MODIFICATION OF A GLYCOPROTEIN USING A GLYCOSYLTRANSFERASE THAT IS OR IS DERIVED FROM A β(1,4)-N-ACETYLGALACTOSAMINYLTRANSFERASE
|
|
WO2017124084A1
(en)
*
|
2016-01-15 |
2017-07-20 |
University Of Maryland, College Park |
Endo-s2 mutants as glycosynthases, method of making and use for glycoengineering of glycoproteins
|
|
AU2017214441B2
(en)
|
2016-02-04 |
2021-08-19 |
Genovis Ab |
New Streptococcal proteases
|
|
WO2018039373A1
(en)
*
|
2016-08-24 |
2018-03-01 |
Cho Pharma Inc |
Endoglycosidase mutants for glycoprotein remodeling and methods of using it
|
|
CN111183220B
(zh)
|
2017-05-26 |
2024-03-22 |
杰诺维斯公司 |
用于聚糖分析的工具
|
|
US20210228738A1
(en)
|
2017-07-17 |
2021-07-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins
|
|
CN112672764A
(zh)
|
2018-06-19 |
2021-04-16 |
格莱科斯生物医药公司 |
结合物
|
|
US20210138080A1
(en)
|
2018-06-29 |
2021-05-13 |
Glykos Biomedical Oy |
Conjugates
|
|
WO2021123506A1
(en)
|
2019-12-18 |
2021-06-24 |
Glykos Biomedical Oy |
Stabile conjugate
|
|
CN111044731B
(zh)
*
|
2019-12-19 |
2021-05-07 |
北京科技大学 |
脉冲温育免疫反应分离富集多肽药物中肽类杂质的方法
|
|
BR112022013255A2
(pt)
|
2020-01-09 |
2022-09-06 |
Mersana Therapeutics Inc |
Conjugados anticorpo-fármaco específicos de sítio com ligantes contendo peptídeo
|
|
GB202002072D0
(en)
*
|
2020-02-14 |
2020-04-01 |
Hansa Biopharma AB |
immunoglobulin detection and associated therapies
|
|
CN120078887A
(zh)
*
|
2020-09-21 |
2025-06-03 |
上海宝济药业股份有限公司 |
一种药物组合及其应用
|
|
MX2023008000A
(es)
|
2021-01-04 |
2023-07-13 |
Mersana Therapeutics Inc |
Conjugados de anticuerpo dirigido a b7-h4 y farmaco, y metodos de uso de los mismos.
|
|
EP4079848A1
(en)
|
2021-04-22 |
2022-10-26 |
Genovis Ab |
Immunoglobulin cleaving enzyme
|
|
CN115873833B
(zh)
*
|
2022-11-08 |
2024-08-16 |
上海泰昶生物技术有限公司 |
生产免疫球蛋白g降解酶的工程菌株和工艺
|
|
CN117165643B
(zh)
*
|
2023-08-17 |
2025-10-28 |
山东大学 |
一种糖苷内切酶在水解高甘露糖型n-糖蛋白中的应用
|
|
WO2025098484A1
(zh)
*
|
2023-11-10 |
2025-05-15 |
上海齐鲁制药研究中心有限公司 |
新型Endo S2突变体酶
|
|
WO2025180451A1
(zh)
*
|
2024-03-01 |
2025-09-04 |
上海齐鲁制药研究中心有限公司 |
新型Endo S2突变体酶
|
|
WO2025248500A1
(en)
|
2024-05-31 |
2025-12-04 |
Janssen Biotech, Inc. |
Antibody drug conjugates that target enpp3
|
|
GB202413764D0
(en)
|
2024-09-18 |
2024-10-30 |
Genovis Ab |
Immunoglobulin proteases and their uses
|